1) China's drug research and development and production capacity is poor, and the better drugs are imported, which is not expensive. Many American drugs and devices are more expensive in China than in the United States.

2) There are too many circulation links, and there are too many hands that want to get involved in oil and water. The doctor is only the weakest link you can see, and when it is exposed, it is pushed out as a shield when something happens; Hiding in the back is the big head.

well, that's the trick.

suppose that after the price of drugs is reduced, there is less rebate for doctors, so doctors have less motivation to overtreatment-but it is not.

It depends on many factors, drug competition, profit margins of manufacturers, etc. In the long run, the impact on drug rebates is unknown, and the high probability event is that the overall drug rebate will be reduced.

Although the price of outpatient service has increased, the outpatient service charge is not high, and it also accounts for a small proportion of hospital income. After the cancellation of drug addition and the decrease of testing cost, the overall income of the hospital declined, and the increase of outpatient income could not offset the decrease of other income, and the state did not increase subsidies.

under the general environment that the overall income of the hospital does not rise, it is very unlikely that the income of doctors will remain unchanged or rise because of the increase in outpatient fees. Of course, the division of a single clinic is definitely more than before, so some users in Zhihu said that some doctors have to make a clinic into several clinics, which is really drunk!

Of course, some departments have increased their benefits, such as the tumor radiotherapy department. Because it is mainly medical services, the price increase is medical services. At present, there are very few departments that benefit from medical reform.

of course, after the price increase, the outpatient fee in China is still not expensive, and the outpatient experience is really poor. These are two problems that are difficult to reconcile at the same time. They can't always be cheap and good, which doesn't conform to the basic principles.

Assuming that the doctor's income mainly depends on drug kickbacks, then after the doctor's income increases due to the increase in outpatient fees, the doctor will suddenly restrain himself from prescribing drugs indiscriminately and overtreatment-however, it is not.

China has its initial background and motivation to support doctors with medicine, but it has now become a basic hidden rule. Even if the doctor's sunshine income rises sharply, it will not necessarily change the habit of taking kickbacks. Change this through systematic and long-term efforts, not doctor's self-discipline or morality.

The United States, Japan, Taiwan Province and other places have experienced this situation in China, and it took a long time to change. On the one hand, it can improve doctors' sunshine income, on the other hand, it can strictly enforce various review and punishment mechanisms, and on the other hand, it can implement elite education to improve doctors' access threshold.